  Preterm neonates represent one of the most transfused categories of patients. Their target hematocrits , however , are mainly based on expert opinion. The risk of transfusions are very high in the smallest preterm baby with a weak immune response , immature antioxidant ability , fragile germinal matrix and impaired cerebral autoregulation , yet red cell transfusions remain the only life saving measure in the baby with symptomatic anemia<symptom> Minimizing phlebotomy losses , following a restrictive transfusion policy and using screened , leukocyte depleted , irradiated , single donor blood remain the best means of avoiding the possible risks while maximizing the benefits of red cell transfusions in the preterm newborn.